Scope
NICE NG207 frames labour induction as a shared decision that depends on gestation, membrane status, previous uterine surgery, cervical assessment and fetal wellbeing. This selected summary covers common timing and method decisions, monitoring and key escalation rules. It preserves the right to decline or stop induction and separates a method choice from a complete drug-administration protocol.
Written by House with AI assistance · AI-assisted source check 29 October 2026.
This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.
Make an informed, revisitable birth plan
- Discuss the reason, timing, setting, proposed method, pain relief and alternatives before induction. Explain that induction can change birth options, may be more painful and can fail; record the person’s preferences and decisions. [1]
- Allow time for questions and discussion with chosen supporters. Respect and document a decision to proceed, delay, decline or stop induction, even if the clinical team disagrees. [1]
Discuss changing risks after term
- Give uncomplicated pregnancies an opportunity for spontaneous labour. Discuss that induction from 41+0 weeks may reduce increasing risks of caesarean birth, neonatal intensive-care admission, stillbirth and neonatal death, while also affecting the birth experience. [1]
- If induction is declined, discuss expectant management or caesarean birth and whether additional monitoring is wanted from 42 weeks. Explain that monitoring is only a snapshot and cannot reliably predict or prevent stillbirth; advise prompt contact for reduced or altered fetal movements. [1]
Keep preterm and term membrane-rupture decisions distinct
- With preterm prelabour membrane rupture before 34+0 weeks, do not induce unless another obstetric indication, such as infection or fetal compromise, exists. After 34+0 but before 37+0 weeks, discuss induction versus waiting until 37+0, considering maternal and neonatal risks, neonatal facilities and preferences. [1]
- For prelabour membrane rupture at or after 37+0 weeks, offer a choice of induction as soon as possible or expectant management for up to 24 hours. If labour has not begun after approximately 24 hours of waiting, offer induction while respecting a decision to continue waiting. [1]
- With membrane rupture after 34+0 but before 37+0 weeks and a positive group B streptococcus test in the current pregnancy, offer immediate induction or caesarean birth. The same immediate-birth choice applies to term membrane rupture with current-pregnancy GBS positivity. [1]
Identify situations needing a separate birth strategy
- After a previous caesarean, discuss emergency-caesarean and uterine-rupture risks, mechanical methods and repeat caesarean. The cited product authorisations contraindicate dinoprostone and misoprostol for induction with a uterine scar because of rupture risk. [1]
- Induction is generally not recommended for breech presentation. Consider it only when birth must be expedited, external cephalic version has failed or is declined or contraindicated, and planned caesarean is declined. For growth restriction with confirmed fetal compromise, offer caesarean instead of induction. [1]
- After intrauterine fetal death, offer emotional and specialist support. If physically well with intact membranes and no bleeding or infection, discuss expectant management, induction or caesarean; ruptured membranes, infection or bleeding call for immediate induction or caesarean. [1]
Choose the method after assessment and consent
- After 39+0 weeks, discuss membrane sweeping and obtain verbal consent. Explain that it may reduce the need for additional induction methods but may cause pain, discomfort or bleeding; discuss another sweep if labour does not start. [1]
- For a Bishop score of 6 or less, offer an appropriate vaginal dinoprostone preparation or low-dose 25-microgram oral misoprostol tablets. Follow preparation-specific prescribing and monitoring instructions; the cited contraindication in a scarred uterus still applies. [1]
- For a Bishop score of 6 or less, consider a mechanical method when medication is unsuitable, including increased hyperstimulation risk or previous caesarean, or when the person chooses a mechanical method. [1]
- For a Bishop score above 6, offer amniotomy with intravenous oxytocin. Explain that oxytocin can be declined or delayed, but labour may take longer and neonatal infection risk may increase. [1]
Assess suitability and respond to abnormal contractions
- Before induction, assess fetal-head position and stability, use ultrasound if presentation is uncertain, record the Bishop score, and confirm a normal fetal heart pattern and absence of significant contractions. Check prior scans for a low-lying placenta before sweeping or induction; cardiotocography facilities must be available. [1]
- When contractions start after dinoprostone or misoprostol, assess fetal wellbeing and contractions with cardiotocography. If normal and the individual assessment is low-risk, intermittent auscultation may be used unless further cardiotocography is indicated. [1]
- With abnormal fetal heart rate or excessive contractions after induction medication, continue or restart continuous cardiotocography, give no more doses and remove vaginal products if possible. For uterine hyperstimulation, assess the fetus and consider tocolysis. [1]
- Reassess maternal and fetal wellbeing and the Bishop score at intervals appropriate to the method and clinical condition. Provide suitable analgesia and use the dedicated fetal-monitoring pathway once active labour is established. [1]
Plan review and escalation before discharge or further induction
- Consider outpatient vaginal dinoprostone or mechanical induction only for someone wishing to return home who has no coexisting medical condition or obstetric complication. Complete maternal and fetal assessment, establish safety and support arrangements and agree a review plan. [1]
- For outpatient induction, advise contact when contractions start, fail to start within the agreed timeframe, membranes rupture or bleeding develops. Reduced or altered movements, excessive pain or contractions, adverse effects or loss of the pessary also warrant contact. [1]
- If induction fails, reassess maternal and fetal wellbeing, provide support and agree the next plan. Depending on circumstances and preferences, options include a rest and reassessment, expectant management, another attempt or caesarean birth. [1]
- Suspected uterine rupture during induced labour requires immediate category 1 caesarean birth. This is an emergency escalation rule, not an indication to continue induction. [1]
Limitations and use
- This summary does not reproduce the complete macrosomia discussion, numerical risk appendices, intrauterine-death medication schedules, cord-prolapse pathway or all indications for planned caesarean. Specialist obstetric assessment remains necessary.
- The 25-microgram misoprostol statement identifies the recommended oral tablet option, not a repeat-dose interval or maximum-dose schedule. Product-specific contraindications, monitoring, national protocols and emergency facilities are required.
- UK product authorisations and service arrangements require local applicability review. No unmonitored home induction or universal gestational-timing rule is established by these selected recommendations.
This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.
Summary sources
- Inducing labour
Selected recommendation material consulted
Publication details
- Issuing organisation
- NICE
- First published
- 4 November 2021
- Resource type
- Clinical guideline · House clinical summary
The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.